Body Composition, Metabolic Health, and Anti-Inflammatory Properties

What CLA Is and Where It Comes From

CLA is not a single compound but a family of geometric and positional isomers of linoleic acid (an omega-6 fatty acid). The two most biologically active forms are:

• cis-9, trans-11 CLA (c9,t11): The predominant form in food; also called rumenic acid. Produced in the gut of ruminants via bacterial biohydrogenation of linoleic acid, and also synthesized in human tissue from vaccenic acid (a related fatty acid also found in grass-fed dairy). This is the form associated with anti-cancer and anti-inflammatory properties.
• trans-10, cis-12 CLA (t10,c12): Found in smaller amounts in food but the dominant form in most commercial supplements. Associated with body fat reduction effects, but also with some metabolic side effects at high doses, including insulin resistance and elevated inflammatory markers in certain populations.

Food sources (approximate CLA content per gram of fat):

• Grass-fed butter: 4–6 mg/g fat (vs. 1–2 mg/g in conventional butter)
• Grass-fed beef: 3–4 mg/g fat (vs. 0.5–1.5 mg/g in grain-fed beef)
• Full-fat grass-fed dairy (cheese, whole milk): 3–6 mg/g fat
• Grass-fed lamb: similar to grass-fed beef

A typical diet with some grass-fed dairy and meat provides roughly 100–300 mg CLA per day. Clinical trials showing body composition effects have typically used 3.2–6.4 g/day as supplements — roughly 10–30 times the average dietary intake. This dose gap is important context when evaluating research.

Body Composition Effects

The most extensively studied application of CLA is its effect on body fat. A 2007 meta-analysis by Whigham et al. pooled 18 randomized controlled trials and found that CLA supplementation (at doses averaging around 3.2 g/day) produced approximately 0.09 kg greater fat loss per week compared to placebo — a modest but statistically consistent effect across studies lasting up to six months [1]. The effect appeared dose-dependent and plateaued around 3–4 g/day.

A more recent and larger 2024 meta-analysis (Asbaghi et al.) synthesized 70 RCTs involving 4,159 participants and found CLA significantly reduced body weight, BMI, waist circumference, and body fat percentage by approximately 0.77 percentage points [2]. However, the authors noted that higher-quality studies within the analysis showed substantially less pronounced effects — suggesting that study quality and publication bias may inflate the apparent benefit in older literature.

Proposed mechanisms include:

• Inhibition of lipoprotein lipase (LPL): CLA reduces LPL activity in fat cells, slowing the uptake of dietary fat into adipose tissue.
• Enhanced fat oxidation: CLA appears to shift metabolism toward fat burning, partly via activation of PPARα (a nuclear receptor that regulates fatty acid oxidation in muscle and liver).
• Reduced lipogenesis: CLA suppresses enzymes involved in de novo fat synthesis, including fatty acid synthase (FAS).
• Apoptosis of fat cells: Some evidence suggests CLA promotes programmed death of mature adipocytes, reducing adipose tissue mass.

Practical reality: The fat loss from CLA at supplement doses is real but modest — likely 0.5–2 kg of additional fat loss over several months compared to placebo, without changes to diet or exercise. This is not a meaningful weight loss intervention on its own but may contribute marginally to body composition goals alongside broader lifestyle changes.

Anti-Inflammatory Mechanisms

The c9,t11 isomer of CLA (the form predominant in food) activates PPARγ — a nuclear receptor that plays a central role in regulating inflammatory gene expression. In a controlled animal study, beef enriched to 4.3% CLA (representing the natural CLA content of pasture-raised beef at high intake) significantly reduced circulating and adipose tissue inflammatory markers including IL-1β, IL-12p70, and IFN-γ compared to conventional low-CLA beef [5]. The mechanism involved PPARγ-mediated downregulation of toll-like receptor 4 (TLR4) — the receptor that initiates inflammatory cascades in response to bacterial lipopolysaccharide.

This is mechanistically significant because TLR4 activation from intestinal lipopolysaccharide (released by gram-negative gut bacteria) is now recognized as a driver of metabolic inflammation — the low-grade systemic inflammation underlying insulin resistance, obesity, and cardiovascular disease. CLA from grass-fed food sources may attenuate this pathway at physiologically achievable doses, which is different from the higher-dose supplement effects on body composition.

Cancer Research

The most provocative CLA research involves its potential to modify cancer-relevant pathways. A 2013 proof-of-principle clinical trial (McGowan et al.) enrolled 24 women with newly diagnosed breast cancer who had not yet undergone surgery [4]. Participants received either 7.5 g/day of CLA supplements or placebo for approximately 2–6 weeks pre-surgery. Tissue biopsies taken at surgery were compared to pre-treatment biopsies for markers of lipogenesis and proliferation.

CLA significantly reduced expression of S14 protein (p=0.003), a lipogenic transcription factor overexpressed in aggressive breast cancers, and decreased Ki-67 staining (p=0.029), a standard marker of cell proliferation. No significant toxicity was observed. The authors were careful to describe this as a proof-of-principle trial demonstrating target engagement — not evidence of clinical efficacy against cancer. Larger and longer trials would be needed to determine whether CLA supplementation reduces cancer incidence or progression.

This research aligns with extensive in vitro and animal evidence showing CLA suppresses tumor growth in mammary, colorectal, lung, and prostate cancer models, largely through PPARγ activation, reduced lipogenesis (cancer cells are highly lipogenic), and modulation of inflammatory signaling.

Cardiovascular Effects

A 2024 GRADE-assessed meta-analysis (Esmaeilnejad et al.) evaluated 14 RCTs examining CLA's effect on cardiovascular risk factors [3]. CLA significantly reduced body weight (by 0.72 kg), BMI (0.22 kg/m²), and fat mass (1.32%) — consistent with body composition findings — but showed no statistically significant effect on blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, or fasting blood glucose. The GRADE quality assessment rated the certainty of evidence as low to very low for most outcomes, reflecting study heterogeneity and methodological limitations.

An important caution: Some studies using high-dose CLA supplements (particularly those delivering the t10,c12 isomer in isolation, as in many commercial supplements) have found worsening insulin sensitivity, elevated fasting glucose, and increased oxidative stress markers. These effects appear more likely at doses above 6 g/day and with specific isomer profiles. Food-derived CLA (predominantly c9,t11) does not appear to carry these risks at typical dietary intakes.

CLA in Grass-Fed Versus Grain-Fed Animal Products

The grass-fed difference is substantial and well-documented. Ruminants produce CLA via bacterial biohydrogenation of the linoleic acid and alpha-linolenic acid abundant in pasture grass. When cattle are switched to grain-based diets (typically corn and soy), their gut microbiome shifts and CLA production drops 2–5 fold [5].

This means that choosing grass-fed and pasture-raised dairy and beef provides:

• 2–5 times more dietary CLA per gram of fat
• Higher concentrations of the c9,t11 isomer (the food-native, better-studied form)
• Higher omega-3 fatty acids and vaccenic acid alongside CLA
• All within a whole-food matrix with additional nutrients

For those who want to increase CLA intake through food rather than supplements, consistently choosing full-fat grass-fed dairy (butter, cheese, whole milk) and grass-fed beef is a pragmatic approach that delivers the c9,t11-dominant form in its natural context.

Practical Considerations

If eating food sources: Prioritize full-fat grass-fed dairy and grass-fed beef. Higher fat dairy products contain more CLA per serving simply because they contain more fat. Grazing on fresh grass produces more CLA than stored hay, so seasonal grass-fed products (late spring through fall) may be particularly rich.

If supplementing: Commercial CLA supplements are typically derived from safflower oil and deliver a higher proportion of the t10,c12 isomer than food. If you supplement, look for products specifying the isomer ratio or derived from natural sources. Start at 3 g/day rather than higher doses. People with type 2 diabetes or significant insulin resistance should be cautious, as some evidence suggests the t10,c12 isomer may worsen insulin sensitivity at higher doses.

Realistic expectations: CLA is not a meaningful fat-loss tool in isolation. The modest body composition effect at supplemental doses is real but unlikely to be noticed without consistent dietary and exercise context.

See our Grass-Fed Meat page for more on the nutritional differences between pasture-raised and grain-fed animal products, and our Omega-3 page for how omega-3 fatty acids in grass-fed products complement CLA's anti-inflammatory effects.